Roberto Lozano-Rodríguez

16PUBLICATIONS
50CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Haematological tumoursInnate immunityTumour immunologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 02, 2026
Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation.

Flavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde

|Feb 27, 2026
A Circulating Signature of Tumour Hybrid Cells and Immune Checkpoints Predicts Metastatic Progression in Lung Cancer.

Gonzalo Sáenz de Santa María-Diez, Sandra Liana Pardo-Prieto, Roberto Lozano-Rodríguez

|Feb 27, 2026
Immune Checkpoint Signatures Reveal Stage-Specific Biomarkers for High-Activity Multiple Sclerosis.

MariPaz López-Molina, Gabriel Torres Iglesias, Laura Vidal

|Apr 13, 2023
Thiosulfinate-Enriched Allium sativum Extract Exhibits Differential Effects between Healthy and Sepsis Patients: The Implication of HIF-1α.

José Avendaño-Ortiz, Francisco Javier Redondo-Calvo, Roberto Lozano-Rodríguez

|Feb 01, 2023
The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification.

José Avendaño-Ortiz, Manuel Ponce-Alonso, Emilio Llanos-González

Pageof 3